DDW: Rifaximin Cuts Peritonitis in Cirrhosis (CME/CE)

CHICAGO (MedPage Today) — The nonabsorbable antibiotic rifaximin appeared to reduce the incidence of bacterial peritonitis in patients with advanced liver cirrhosis, according to a study presented here.

Post a Comment

Comments are closed.